Nellix Receives $105,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2465-B Faber Place Palo Alto, CA 94303
  • Company Description
    Nellix has developed a revolutionary, percutaneously deliverable endograft for the treatment of Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms. This aortic endograft device and treatment fills the aneurysm, providing a highly stable and durable seal. The novel technology enables treatment of all aortic aneurysms and provides a distinct advantage over current therapies.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Band of Angels

Trending on Xconomy